Frank Zhang
China General Manager, IVF Commercial Head
Frank Zhang serves as Heranova’s Diagnostic BU General Manager. Mr. Zhang has more than 20 years of experience in the healthcare and life science industries where he has continuously developed high-performing teams that achieve and exceed commercial goals.
Frank joined Veritas Genetics China in 2016 as Sales and Marketing Vice President. From 2016 to 2019, Frank led commercial development for the personal genome business and clinical genetic diagnostic test business in prenatal and newborn indications. Since 2019 when Veritas Genetics China was acquired by Igenomix, Frank has served as Country Manager for China for the reproductive and genomic prenatal diagnostic testing business. In 2022, Igenomix China was acquired by Heranova.
Prior to Veritas Genetics, Frank held commercial leadership roles at St. Jude Medical, Philips Healthcare, and Amgen, in China, APAC, and the USA.
Frank received his Bachelor of Clinical Medicine from the Shanghai Medical College Fudan University and his MBA from the University of North Carolina at Chapel Hill.
Frank joined Veritas Genetics China in 2016 as Sales and Marketing Vice President. From 2016 to 2019, Frank led commercial development for the personal genome business and clinical genetic diagnostic test business in prenatal and newborn indications. Since 2019 when Veritas Genetics China was acquired by Igenomix, Frank has served as Country Manager for China for the reproductive and genomic prenatal diagnostic testing business. In 2022, Igenomix China was acquired by Heranova.
Prior to Veritas Genetics, Frank held commercial leadership roles at St. Jude Medical, Philips Healthcare, and Amgen, in China, APAC, and the USA.
Frank received his Bachelor of Clinical Medicine from the Shanghai Medical College Fudan University and his MBA from the University of North Carolina at Chapel Hill.